Recent Headlines
Within Pharmaceuticals
Arlington Free Clinic Hosts Senator Adam Ebbin and Rx Partnership Board of Directors
State Senator Adam Ebbin (D-30th) and Rx Partnership’s Board of Directors toured the Arlington Free Clinic (AFC) on December 4 during the board’s quarterly meeting. Senator Ebbin and board members were able to learn about the clinic’s daily operations, challenges the clinic faces... - December 30, 2015 - Rx Partnership
World Parkinson’s Program Provides Quad Canes and Educational Material to Support Parkinson’s Patients in Kenya
World Parkinson's Program announces the continuation of its' "Fall Prevention Campaign" by delivering educational material to Africa Parkinson's Association. The material will aid those who suffer from Parkinson's disease and would not be able to afford healthcare supplies otherwise. - December 19, 2015 - World Parkinson's Program
National Brain Tumor Society Opens New Funding Call for Its Oligodendroglioma Research Fund
Request for Applications seeks proposals for research on clinically relevant biomarkers for oligodendroglioma tumors, closes January 15, 2016. - December 18, 2015 - National Brain Tumor Society
MiTeGen Announces Diode Beam Stop License Agreement with Lawrence Berkeley Laboratory
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed an exclusive licensing agreement with Lawrence Berkeley National... - December 17, 2015 - MiTeGen, LLC
VIRUN NutraBIOsciences Collaborates with Otwo Biotech Shenzhen; 6 New Patent Applications in 2015; Virun’s New Facility is High-Tech; New Webinar Takes a Look Inside
VIRUN continues its’ interstellar growth by working with Chinese company Otwo Biotech of Shenzhen to bring new highly concentrated EPA DHA Omega products to market. Six new patent applications added to an already robust holdings. Virun’s new facility in Pomona, CA. nears completion and boasts State of the Art, eco-friendly functionalism, that includes heightened spray drying capabilities. A Live, upcoming Webinar, Feb. 2016, showcasing an "Inside Look" into VIRUN manufacturing and R&D. - December 16, 2015 - VIRUN
2016 Healthcare Trends: Population Health Prevails in Pay-for-Value Realm
Population health management remains the most influential factor in healthcare business operations for the second consecutive year, according to a complimentary trends snapshot by the Healthcare Intelligence Network (HIN). - December 15, 2015 - Healthcare Intelligence Network
Hemophilia Treatment ACE910 Bypasses Factor VIII Inhibitor in Affinity Biologicals Plasmas
Chugai Pharmaceutical's newly developed antibody ACE910 is a potential lifesaving treatment for Hemophilia A patients who have developed Factor VIII inhibitors. A first-in-human study (1) recently published by the American Society of Hematology indicates that ACE910 may be a safe and effective treatment for hemophilia A patients. - December 11, 2015 - Affinity Biologicals
Research Square Announces Video Summaries Solution to Help Researchers Communicate Their Work More Effectively
Research Square is partnering with MyScienceWork to offer engaging Video Summaries of research through the Polaris platform for universities and institutions. - December 11, 2015 - Research Square
World Parkinson’s Program Refugees Initiative
World Parkinson’s Program announces the launch of a series of educational campaigns for raising awareness of Parkinson’s disease and dementia in Syrian refugees arriving to Canada. “In the special Syrian refugee clinics set up by Canadian physicians, World Parkinson’s... - December 10, 2015 - World Parkinson's Program
Recursion Pharmaceuticals Receives $2.6 Million in Follow-on Seed Funding
Funding will be used to accelerate and scale the company’s proprietary drug discovery platform. - December 08, 2015 - Recursion Pharmaceuticals
NuvOx Pharma Receives FDA Orphan Drug Designation for Radiosensitizer for Glioblastoma
Tucson based pharmaceutical company NuvOx Pharma announced today that it has secured orphan drug designation from the FDA for its investigational drug NVX-108 for treatment of Glioblastoma. Orphan status provides NuvOx with development and commercial incentives such as tax credits for qualified clinical testing and market exclusivity for 7 years after the marketing approval is granted. - December 07, 2015 - NuvOx Therapeutics
ImaBiotech’s Multimaging™ Technology Chosen by Dermira for Its Skin Disposition Study
ImaBiotech today announced that Dermira, Inc., a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and their patients, chose ImaBiotech’s Multimaging technology for a skin disposition study in Yorkshire pigs. Dermira presented the... - December 07, 2015 - Imabiotech
Saint-Gobain Seals Installs New Automation Machine That Manufactures OmniSeal® Spring-Energized Seals
Saint-Gobain Seals installs new automation machine at Willich, Germany site, which forms and assembles OmniSeal® spring-energized seals. Adding this new equipment not only allows the business to assemble the product in large quantities but also maintain their high standard of world class manufacturing and quality. - December 04, 2015 - Saint-Gobain Performance Plastics, Seals Group
Speaking of NEC Podcast Featuring Neonatal Ergonomics Expert Yamile Jackson Recently Launched
Produced by The Morgan Leary Vaughan Fund, and funded by The Petit Family Foundation, Speaking of NEC is a series of one-on-one conversations with relevant Necrotizing Enterocolitis (NEC) experts-neonatologists, clinicians and researchers-that highlights current prevention, diagnosis, and treatment strategies for NEC, and the search for a cure. - December 03, 2015 - The Morgan Leary Vaughan Fund, Inc.
F2G Ltd Announces the Acceptance of F901318 to Participate in the EMA’s Adaptive Pathways Pilot Programme
F2G Ltd, a UK based antifungal drug discovery and development company, today announced that its novel systemic antifungal product F901318 has been accepted to participate in the European Medicines Agency’s (EMA) Adaptive Pathways pilot programme. Initiated in March 2014, the Adaptive... - December 03, 2015 - F2G Ltd
IQ4I Research & Consultancy Published a New Report on “Neuromodulation Devices Global Market": Estimated to be Worth $9.3 Billion by 2021
Neuromodulation device market represents therapies specifically designed to deliver electrical current through internally implanted or externally stimulating devices to bring about desired change in nervous system. - December 03, 2015 - IQ4I Research & Consultancy Pvt. Ltd.
Detectamet Tags Protect Critical Data from Shock Destruction
How do you identify and trace food batches passing through your process? Detectamet detectable processing ID tags reduce the risk of lost data. They will survive high/low temperature parameters and ensure ID traceability and data correlation. They reduce the risk of food product contamination because they are metal detectable. - December 03, 2015 - Detectamet
Global IoT Security Market is Expected to Reach USD 464 Million in 2020
IoT Security Market for Utilities, Automotive, Healthcare and Other End-users: Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 - 2020. - December 01, 2015 - Market Research Store
Product Spotlight: Introducing Factor V Coagulation Antibodies from Affinity Biologicals Inc.
The human heart is an amazing vessel that pumps blood throughout the body, but sometimes genetic mutations make it difficult for the cardiovascular system to function the way it should. Most people inherit the factor V protein gene, which promotes healthy blood clotting throughout the body. Unfortunately, some inherit the factor V Leiden gene, which does just the opposite and prevents blood from clotting normally. - November 30, 2015 - Affinity Biologicals
Sydney Company Wins State Funding to Make HIV Self Test
Atomo Diagnostics awarded A$1.8 mil from the NSW Medical Device Fund to develop innovative HIV self test in Australia. - November 28, 2015 - Atomo Diagnostics
Best Practices for Antibiotic Use
Antibiotic resistance is one of the largest health issues facing the world in the next few years. Earlier this month, the World Health Organization held Global Antibiotic Awareness Week. Aceso Care worked to translate content released by the World Health Organization into Urdu to spread awareness... - November 28, 2015 - Aceso Care
Dr. Sebag Brings the Floaters Discussion to Paris; Dr. Sebag Presents VMR's Floater Program Findings to the French Ophthalmology Society’s Annual Meeting in Paris, France
Dr. Sebag presented VMR's floater program findings at the French Ophthalmology Society’s annual meeting in Paris. He described curing floaters with a limited vitrectomy where only the offending vitreous tissue opacities are removed, as opposed to the entire vitreous. This outpatient operation is performed in just 10 minutes, without sutures, under local anesthesia. The effectiveness of this surgery has been published in worldwide and patients are increasingly requesting the treatment. - November 26, 2015 - VMR Institute
How California Became the Center of the Stem Cell Universe - And Why That Matters to You
When Don Reed's son Roman was paralyzed in a college football game, the two began a 21 year quest for cure-- not just for paralysis, but for all forms of "incurable" disease. Joining with Bob Klein, father of a diabetic son, the Reeds helped pass Proposition 71, the California Stem Cells for Research and Cures Act. What happened next was a quiet triumph, step-by-step progress toward the cure of diseases which have plagued mankind for millennia. - November 25, 2015 - Americans for Cures Foundation
ASSIST Wins Big at IDTechEx Wearable USA 2015
With a vision to achieve a comprehensive assessment of health and environment through wearable technologies that enable multi-modal sensing, the ASSIST Center excels at making hassle-free and reliable nano-enabled devices for on body sensing. At the most recent IDTechEx Wearable USA conference the ASSIST Center and Dr. Zhu captivated judges winning an award: Best Wearable Material/Component Development. - November 25, 2015 - ASSIST Research Center
IQ4I Research & Consultancy Published a New Report on “Active Pharmaceutical Ingredients Global Market": Estimated to be Worth $173.5 Billion by 2020
The global Active Pharmaceutical Ingredients market is expected to reach $173.5 billion by 2020. This report analyzes the API market in terms of market revenue ($ Billion) for all segments, analysis is performed by synthesis type (Synthetic Chemicals API, Biotech API, HPAPI), Business type (Captive and Merchant) and therapeutic applications. - November 25, 2015 - IQ4I Research & Consultancy Pvt. Ltd.
Bioo Scientific Launches Completely Gel-Free or Low Input Small RNA Library Prep Kit
Bioo Scientific recently launched the NEXTflex™ Small RNA-Seq Kit v3, which improves small RNA analysis by making the library prep protocol completely gel-free or allowing for low-input small RNA library preparation. This kit also reduces the biases associated with small RNA sequencing by... - November 25, 2015 - Bioo Scientific
The MaxSignal Colistin ELISA Test Kit Can Help Prevent the Antibiotic Apocalypse by Keeping Last Resort Drugs Out of the Food Supply
Colistin resistance likely emerged after the drug was overused in farm animals. Colistin is intended to be used by physicians as a drug of last resort to treat Gram-negative superbug infections, but has been overused in agriculture. Bioo Scientific’s MaxSignal® Colistin ELISA Test Kit is the only commercially available ELISA optimized for the screening of colistin in poultry and other meat samples and eggs, to prevent the spread of colistin resistance by keeping colistin out of the food supply. - November 25, 2015 - Bioo Scientific
Aurora Scientific Inc. Unveils New Brand and Celebrates the Official Opening of a New Manufacturing Facility
On October 8, 2015, Aurora Scientific, a science and technology firm in Aurora, ON welcomed guests to celebrate the official launch of their new brand and grand opening of their new manufacturing facility. The event brought together local suppliers and dignitaries, valued clients, families and friends, marking a milestone for the growing company. - November 21, 2015 - Aurora Scientific Inc.
Altogen Biosystems In Vivo Pancreas Kit Has Applications for Diabetes Mellitus and Pancreatic Cancer
As featured by Science magazine, Altogen Biosystems offers a popular line of in vivo transfection reagent kits that include polymer, liposome, nanoparticle and PEG-liposome-based in vivo transfection kits as well as in vivo kits dedicated to targeting tissues, one of which is highlighted here: the... - November 21, 2015 - Altogen Biosystems
Noninvasix Among Finalists in 2015 HITLAB World Cup℠ International Healthcare Competition
Of the more than 192 international teams that submitted innovative healthcare solutions, five companies, including Noninvasix, Inc., will compete for $18,000 in total prize money at the HITLAB World Cup℠ finals held at Columbia University in New York City, December 4. Organized by New York... - November 21, 2015 - Noninvasix
Two Research Reports Cite HemogloBind™ for Highly Efficient Sample Preparation
Biotech Support Group reports on two recent research reports which describe the simplicity and efficiency of their proteomic sample preparation technology for hemoglobin depletion. - November 20, 2015 - Biotech Support Group
Update on Glycomics - Achieve Safe, Easy, and Accurate O-Glycan Analysis with BlotGlyco® O-Glycan Sample Preparation Kit
MoBiTec to launch Sumitomo's BlotGlyco® O-Glycan Sample Preparation Kit, a streamlined process for releasing and purifying O-glycans for detection by HPLC, LC-MS, and MALDI-TOF MS. - November 19, 2015 - MoBiTec GmbH
Monica Monici, the Scientific Director of ASAlaser Scientific Research Department, was Elected ELGRA President
Dr Monica Monici was appointed to a high office in the non-profit International Scientific Society devoted to the promotion of scientific research under various gravity conditions. - November 19, 2015 - ASA srl
Mercy Receives FDA Award for Medical Device Tracking
Collaborative agreement could be worth up to $5.2 million over three years. - November 18, 2015 - Mercy
EternoGen Aesthetics Completes Its Financing Round Securing $5MM to Commercialize Their First in Class Bio-Dermal Restoration Portfolio
EternoGen Aesthetics, LLC developer and manufacturer of advanced collagen scaffolds, announces the successful completion of its financial round. It has secured $5MM to prepare for the 2016 European commercialization of Rapid Polymerizing Collagen (RPC Pure-Collagen), the first of a rich pipeline of... - November 18, 2015 - EternoGen Aesthetics LLC
ReproTech Staff Discuss Fertility Preservation Options for Oncology Patients in Ft. Worth, TX
Cancer Care Services in Fort Worth, TX was the setting for a presentation entitled Fertility Preservation for the Oncology Patient. This program strives to promote education and extend access to fertility preservation services. - November 18, 2015 - ReproTech, LLC
Is this Detectamet’s Perfect Food Processing Pen?
Why does Detectamet’s Elephant pen meet the requirements of a perfect pen for safe use in the food industry? An unsolicited report from a new user provides an explanation. - November 18, 2015 - Detectamet
IQ4I Research & Consultancy Published a New Report on "Immunotherapeutics Global Market" and Estimated to be Worth $138.9 Billion by 2021
The immunotherapeutics field is rapidly advancing at an unprecedented rate, as estimated by IQ4I Research that the immunotherapeutics global market is expected to reach $138.9 billion by 2021. - November 18, 2015 - IQ4I Research & Consultancy Pvt. Ltd.
New Metrics on Value-Based Healthcare: Adopters Report Healthy Savings, Prevention Gains
Seventy-one percent of healthcare companies employ value-based reimbursement strategies, with one-fifth reporting savings of up to $500,000 annually, according to new market metrics from the Healthcare Intelligence Network (HIN). - November 17, 2015 - Healthcare Intelligence Network
BUHLMANN Laboratories Announces New, Direct US Affiliate
BÜHLMANN Laboratories is proud to announce the establishment of its North American affiliate, BUHLMANN Diagnostics Corp (BDC) in Southern New Hampshire. - November 16, 2015 - BUHLMANN Diagnostics Corp
Prosidyan Announces FDA 510(k) Clearance of FIBERGRAFT BG Morsels for Postero-Lateral Spinal Fusion
NJ-based Prosidyan (www.prosidyan.com), developer of proprietary fiber-based bioactive glass products, announced today that it has received FDA 510(k) clearance of FIBERGRAFT BG Morsels for Postero-lateral Spinal Fusion. FIBERGRAFT BG Morsels is an ultra-porous Bone Graft Substitute, made entirely... - November 16, 2015 - Prosidyan, Inc.
LifeFuels Smart Nutrition Bottle Named 2016 CES Innovation Awards Honoree
Award-winning connected health and fitness product bridges crucial gap between nutrition and wearable technology; First portable, single and multi-serve device that gives users the personalized nutrition and hydration they need, when they need it. - November 14, 2015 - LifeFuels
Rite Aid First U.S. Drugstore Chain to Offer Harmonyx Genetic Testing to Customers
Tests help determine most effective medication therapy based on an individual’s genetic makeup - November 12, 2015 - Harmonyx Diagnostics
Successful Atlanta 8.5K Closes Event Season
Walkers and runners at the Nov. 7 Starry Night Atlanta 8.5K raised more than $120,000 to benefit the Pediatric Brain Tumor Foundation. More than 600 supporters gathered for the evening 8.5K at Centennial Olympic Park to honor local children with brain tumors, our Stars: Andrea, Anna, Ascher,... - November 12, 2015 - Pediatric Brain Tumor Foundation
New Acid Catalyst Offers Significant Cost Reductions with Increased Stability
An exciting new acid catalyst from PhosphonicS could help significantly reduce costs and minimise losses in the Pharmaceutical and Chemical industries. The recently launched Phos-Cat4 has been specially designed to be just as effective as the rest of the PhosphonicS acid catalyst range but offer... - November 12, 2015 - PhosphonicS
Pacific Ozone Joins Forces with CHEMetrics to Reduce Costs and Improve Dissolved Ozone Testing Accuracy for the Bottled Water Industry
This new ozone test kit enables water bottlers to quickly and consistently test for residual ozone following the disinfection process with more accurate results at a lower cost. - November 11, 2015 - Pacific Ozone
iTech’s expEDIum Solutions Provide Smooth ICD-10 Transition
iTech’s ICD-10 ready, Secure Web based expEDIum Medical Billing Software and expEDIum Claims Portal Solution have successfully processed thousands of ICD-10 Claims since October 1, 2015. - November 10, 2015 - expEDIum
Kids Central Pediatrics Inc Creates a New Website to Promote Vaccines and Explain Why They Are Given, How They Work, and Information to Combat Anti-Vaccine Sentiment
A website containing videos in an easy to understand format to explain to parents the most common questions. Videos address why each vaccine is given, how the immune system works, why the vaccines are given on a particular schedule, and the differences between viruses and bacteria. This is a unique website where all this information can be accessed in one location. This website will help parents to make a more informed decision regarding immunization. - November 09, 2015 - Kids Central Pediatrics, Inc.
New Year, New Look - Sorbead India Launched New Website Theme
The new website theme is more accessible and easy-to-use compared to the previous one. It has got a brand new look with everything becoming more trendy and user friendly. - November 09, 2015 - Sorbead India
Fannin Innovation Studio Forms Molecular Therapeutics Company Exotect, LLC.
Researchers behind Exotect LLC have honed in on a novel molecular pathway that controls the overproduction of mucus during asthma attacks. More than 25 million people suffer with asthma, a chronic disease in which airways become inflamed, swell and produce excess mucus making it difficult to breathe. - November 07, 2015 - Fannin Partners, LLC